The Recall Desk
ModerateFDA (Devices)·Z-0499-2016·Announced 2015-12-30

Ameditech DrugSmart Dip Drug Test Kits Recalled for Reduced Benzodiazepine Detection

Ameditech is recalling 120 DrugSmart Dip drug test kits because they may show reduced reactivity for two specific benzodiazepine compounds.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class III, which is defined as unlikely to cause adverse health consequences. The issue is a performance defect (reduced reactivity) rather than a direct physical hazard, fitting the Moderate category for minor labeling or performance errors.

Plain-English summary

Ameditech Inc is recalling 120 units of DrugSmart Dip (MET/OPI2)+AMP+BZO+COC+THC, Item No. 30600D. The recall is due to reduced reactivity for up to two of the nineteen benzodiazepine compounds listed in the product insert. The specific compounds affected are Clonazepam and Chlordiazepoxide.

The affected products were distributed nationwide. The recall notice does not specify any reported illnesses or injuries associated with the use of these test kits.

Consumers and healthcare providers should stop using the affected test kits and contact Ameditech Inc for further instructions or a replacement.

The recalled product

Product
DrugSmart Dip (MET/OPI2)+AMP+BZO+COC+THC, Item No. 30600D
Manufacturer
Ameditech Inc
Affected units
120

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • 142122 142699 143170

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 59 recalled by Ameditech Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 59 products in this recall →